Effect of sorafenib (S) starting dose and dose intensity on survival in patients with hepatocellular carcinoma (HCC): Results from a Canadian multicenter HCC database.

被引：1

作者：

Alghamdi, Mohammed Abdullah

Lee-Ying, Richard

Sim, Hao-Wen

Samawi, Haider

Knox, Jennifer J.

Romagnino, Adriana

Ko, Yoo-Joung

Chan, Kelvin K.

Swiha, Mina

Batuyong, Eugene

Cheung, Winson Y.

Tam, Vincent C.

机构：

[1] Tom Baker Canc Clin, Calgary, AB, Canada

[2] Peter MacCallum Canc Ctr, Melbourne, Australia

[3] Univ Calgary, Calgary, AB, Canada

[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Sunnybrook Med Ctr, Torotno, ON, Canada

[6] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada

[7] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.4084

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4084

引用

页数：5